0

Journal Articles

in Cardiac Biomarkers
 101-120 of 189 Articles
JAMA | 
Original Contribution |  May 03, 2006 FREE
Disease and Disadvantage in the United States and in England
James Banks, PhD; Michael Marmot, MD; Zoe Oldfield, MSc; et al.
JAMA. 2006;295(17):2037-2045. doi:10.1001/jama.295.17.2037.
JAMA Dermatology | 
Off-Center Fold |  May 01, 2006
Generalized Maculopapules With Fever and Cervical Lymphadenopathy—Quiz Case
Hae-Woong Lee, MD; Woo-Jin Yun, MD; Sung-Eun Chang, MD; et al.
Arch Dermatol. 2006;142(5):641-646. doi:10.1001/archderm.142.5.641-c.
JAMA Internal Medicine | 
Editor's Correspondence |  February 13, 2006
C-Reactive Protein and Vascular Cell Adhesion Molecule-1 as Markers of Severity in Sickle Cell Disease
Alexandros C. Makis, MD, PhD; Eleftheria C. Hatzimichael, MD; Justin Stebbing, MD, MRCP, PhD; et al.
Arch Intern Med. 2006;166(3):366-368. doi:10.1001/archinte.166.3.366.
JAMA Internal Medicine | 
Original Investigation |  February 13, 2006 FREE
C-Reactive Protein Concentration and Incident Hypertension in Young Adults:  The CARDIA Study
Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; et al.
Arch Intern Med. 2006;166(3):345-349. doi:10.1001/archinte.166.3.345.
JAMA Internal Medicine | 
Original Investigation |  January 09, 2006 FREE
C-Reactive Protein Is a Marker for Human Immunodeficiency Virus Disease Progression
Bryan Lau, PhD, MHS, ScM; A. Richey Sharrett, MD, DrPH; Larry A. Kingsley, DrPH; et al.
Arch Intern Med. 2006;166(1):64-70. doi:10.1001/archinte.166.1.64.
JAMA Ophthalmology | 
Epidemiology |  January 01, 2006 FREE
Are Inflammatory Factors Related to Retinal Vessel Caliber?:  The Beaver Dam Eye Study
Ronald Klein, MD, MPH; Barbara E. K. Klein, MD, MPH; Michael D. Knudtson, MS; et al.
Arch Ophthalmol. 2006;124(1):87-94. doi:10.1001/archopht.124.1.87.
JAMA Internal Medicine | 
Editorial |  November 28, 2005
When Is a New Prediction Marker Useful?:  A Consideration of Lipoprotein-Associated Phospholipase A2 and C-Reactive Protein for Stroke Risk
Philip Greenland, MD; Patrick G. O’Malley, MC, USA
Arch Intern Med. 2005;165(21):2454-2456. doi:10.1001/archinte.165.21.2454.
JAMA Internal Medicine | 
Original Investigation |  November 28, 2005 FREE
Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Ischemic Stroke in Middle-aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
Christie M. Ballantyne, MD; Ron C. Hoogeveen, PhD; Heejung Bang, PhD; et al.
Arch Intern Med. 2005;165(21):2479-2484. doi:10.1001/archinte.165.21.2479.
INCLUDES: CME
JAMA Internal Medicine | 
Editorial |  October 10, 2005
C-Reactive Protein, Heart Disease Risk, and the Popular Media
Russell P. Tracy, PhD; Lewis H. Kuller, MD, MPH
Arch Intern Med. 2005;165(18):2058-2060. doi:10.1001/archinte.165.18.2058.
JAMA Internal Medicine | 
Original Investigation |  October 10, 2005 FREE
High Attributable Risk of Elevated C-Reactive Protein Level to Conventional Coronary Heart Disease Risk Factors:  The Third National Health and Nutrition Examination Survey
Michael Miller, MD; Min Zhan, PhD; Stephen Havas, MD, MPH, MS
Arch Intern Med. 2005;165(18):2063-2068. doi:10.1001/archinte.165.18.2063.
INCLUDES: CME
JAMA Internal Medicine | 
Original Investigation |  September 12, 2005 FREE
Relationship Between Risk Stratification by Cardiac Troponin Level and Adherence to Guidelines for Non–ST-Segment Elevation Acute Coronary Syndromes
Matthew T. Roe, MD, MHS; Eric D. Peterson, MD, MPH; Yun Li, MS; et al.
Arch Intern Med. 2005;165(16):1870-1876. doi:10.1001/archinte.165.16.1870.
JAMA Neurology | 
Original Contribution |  July 01, 2005 FREE
Myopathic Changes Associated With Severe Acute Respiratory Syndrome:  A Postmortem Case Series
Thomas W. Leung, MD; Ka Sing Wong, MD; Andrew C. Hui, MD; et al.
Arch Neurol. 2005;62(7):1113-1117. doi:10.1001/archneur.62.7.1113.
JAMA Internal Medicine | 
Original Investigation |  June 27, 2005 FREE
Effect of Lowering of Homocysteine Levels on Inflammatory Markers:  A Randomized Controlled Trial
Jane Durga, PhD; L. J. H. van Tits, PhD; Evert G. Schouten, MD, PhD; et al.
Arch Intern Med. 2005;165(12):1388-1394. doi:10.1001/archinte.165.12.1388.
JAMA Ophthalmology | 
Clinical Sciences |  June 01, 2005 FREE
Progression of Age-Related Macular Degeneration:  Prospective Assessment of C-Reactive Protein, Interleukin 6, and Other Cardiovascular Biomarkers
Johanna M. Seddon, MD; Sarah George, MPH; Bernard Rosner, PhD; et al.
Arch Ophthalmol. 2005;123(6):774-782. doi:10.1001/archopht.123.6.774.
JAMA | 
Preliminary Communication |  May 11, 2005 FREE
Effects of a 5-Lipoxygenase–Activating Protein Inhibitor on Biomarkers Associated With Risk of Myocardial Infarction:  A Randomized Trial
Hakon Hakonarson, MD, PhD; Sverrir Thorvaldsson, MSc; Anna Helgadottir, MD; et al.
JAMA. 2005;293(18):2245-2256. doi:10.1001/jama.293.18.2245.
JAMA | 
Editorial |  April 06, 2005
Cardiovascular Risk Stratification in Older Patients:  Role of Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels
Martin Schillinger, MD
JAMA. 2005;293(13):1667-1669. doi:10.1001/jama.293.13.1667.
JAMA | 
Original Contribution |  April 06, 2005 FREE
N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults
Caroline Kistorp, MD; Ilan Raymond, MD, PhD; Frants Pedersen, MD; et al.
JAMA. 2005;293(13):1609-1616. doi:10.1001/jama.293.13.1609.
JAMA Dermatology | 
Off-Center Fold |  February 01, 2005
Erythematous Plaques With Fever and Leukocytosis—Quiz Case
Elizabeth Guevara-Gutiérrez, MD; Alberto Tlacuilo-Parra, MD, MSc; Elia Uribe-Jiménez, MD
Arch Dermatol. 2005;141(2):263-268. doi:10.1001/archderm.141.2.263-a.
JAMA Internal Medicine | 
Original Investigation |  January 24, 2005 FREE
Fluctuating Inflammatory Markers in Patients With Stable Ischemic Heart Disease
Peter Bogaty, MD; James M. Brophy, MD, PhD; Luce Boyer, RN; et al.
Arch Intern Med. 2005;165(2):221-226. doi:10.1001/archinte.165.2.221.
JAMA | 
Review |  December 08, 2004 FREE
Birth Weight and Subsequent Cholesterol Levels:  Exploration of the “Fetal Origins” Hypothesis
Rachel Huxley, DPhil; Christopher G. Owen, PhD; Peter H. Whincup, FFPHM; et al.
JAMA. 2004;292(22):2755-2764. doi:10.1001/jama.292.22.2755.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  April 8, 2013
High-Sensitivity Cardiac Troponin T Levels and Secondary Events in Outpatients With Coronary Heart Disease From the Heart and Soul Study
Alexis L. Beatty, MD; Ivy A. Ku, MD, MAS; Robert H. Christenson, PhD; et al.
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Routine Noninvasive Testing and Highly Sensitive Troponin Immunoassays
Giuseppe Lippi, MD; Gianfranco Cervellin, MD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Routine Noninvasive Testing and Highly Sensitive Troponin Immunoassays—Reply
Vinay Prasad, MD; Michael Cheung, MD; Adam Cifu, MD
JAMA Internal Medicine
Original Investigation  |  March 25, 2013
Bias in Associations of Emerging Biomarkers With Cardiovascular Disease
Ioanna Tzoulaki, PhD; Konstantinos C. Siontis, MD; Evangelos Evangelou, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems